| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| AKR1B1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
ALDR1, AR |
7q35 |
4502048 |
231 |
| AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
RAC, PKB, PRKBA |
14q32.32-q32.33 |
M63167 |
207 |
| AKT3 |
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
PKBG, RAC-gamma, PRKBG |
1q43-44 |
AJ245709 |
10000 |
| ANXA1 |
annexin A1 |
ANX1, LPC1 |
9q11-q22 |
X05908 |
301 |
| AP1S2 |
adaptor-related protein complex 1, sigma 2 subunit |
SIGMA1B |
|
4506956 |
8905 |
| ARAF1 |
v-raf murine sarcoma 3611 viral oncogene homolog 1 |
|
Xp11.3-p11.23 |
BC007514 |
369 |
| AREG |
amphiregulin (schwannoma-derived growth factor) |
SDGF |
4q13-q21 |
NM_001657 |
374 |
| ARHA |
ras homolog gene family, member A |
ARH12, RhoA, Rho12 |
3p21.3 |
10835048 |
387 |
| ARHB |
ras homolog gene family, member B |
ARH6, RhoB |
2pter-p12 |
NM_004040 |
388 |
| ARHC |
ras homolog gene family, member C |
ARH9, RhoC |
1p21-p13 |
NM_005167 |
389 |
| ARHG |
ras homolog gene family, member G (rho G) |
RhoG |
11p15.5-p15.4 |
NM_001665 |
391 |
| BAG1 |
BCL2-associated athanogene |
|
9p12 |
Z35491 |
573 |
| BAK1 |
BCL2-antagonist/killer 1 |
CDN1, BCL2L7 |
6 |
U16811 |
578 |
| BATF |
basic leucine zipper transcription factor, ATF-like |
B-ATF, SFA-2 |
14q24 |
5453562 |
10538 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| BAX |
BCL2-associated X protein |
|
19q13.3-q13.4 |
4757837 |
581 |
| BC-2 |
putative breast adenocarcinoma marker (32kD) |
|
|
7656921 |
27243 |
| BCAS2 |
breast carcinoma amplified sequence 2 |
DAM1 |
1p13.3-p21 |
5031652 |
10286 |
| BCL10 |
B-cell CLL/lymphoma 10 |
CARMEN, CIPER, mE10, c-E10, CLAP |
1p22 |
4502378 |
8915 |
| BCL2 |
B-cell CLL/lymphoma 2 |
Bcl-2 |
18q21.3 |
XM_008738 |
596 |
| BCL2L1 |
BCL2-like 1 |
BCLX, BCL2L, Bcl-X, bcl-xL, bcl-xS |
20pter-p12.1 |
BC019307 |
598 |
| BIK |
BCL2-interacting killer (apoptosis-inducing) |
NBK, BBC1 |
22 |
X89986 |
638 |
| BIRC5 |
baculoviral IAP repeat-containing 5 (survivin) |
API4, EPR-1 |
17q25 |
U75285 |
332 |
| BMI1 |
B lymphoma Mo-MLV insertion region (mouse) |
BMI-1, RNF51 |
10p13 |
4885094 |
648 |
| BMP10 |
bone morphogenetic protein 10 |
|
2p13.2 |
7656927 |
27302 |
| BMP5 |
bone morphogenetic protein 5 |
|
6p |
10835090 |
653 |
| BRE |
brain and reproductive organ-expressed (TNFRSF1A modulator) |
|
2p23 |
4757871 |
9577 |
| C12orf2 |
chromosome 12 open reading frame 2 |
HoJ-1 |
12p12.3 |
6005777 |
11228 |
| C17 |
cytokine-like protein C17 |
|
|
8922107 |
54360 |
| CART |
cocaine- and amphetamine-regulated transcript |
|
|
4757909 |
9607 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| CASP2 |
caspase 2, apoptosis-related cysteine protease (neural precursor cell expressed, developmentally down-regulated 2) |
NEDD2, ICH1 |
7q34-q35 |
U13022 |
835 |
| CCL2 |
chemokine (C-C motif) ligand 2 |
SCYA2, MCP1, MCP-1, MCAF, SMC-CF, GDCF-2 HC11, MGC9434 |
17q11.2-q21.1 |
4506840 |
6347 |
| CCL27 |
chemokine (C-C motif) ligand 27 |
SCYA27, ALP, ILC, CTACK, skinkine, ESkine, PESKY, CTAK |
9p13 |
5730034 |
10850 |
| CCND1 |
cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
BCL1, D11S287E, PRAD1, HGNC:988 |
11q13 |
312911 |
595 |
| CCND1 |
cyclin D1 (PRAD1: parathyroid adenomatosis 1) |
BCL1, D11S287E, PRAD1, HGNC:988 |
11q13 |
X59798 |
595 |
| CCND2 |
cyclin D2 |
|
12p13 |
M90813 |
894 |
| CCNH |
cyclin H |
|
5q13.3-q14 |
4502622 |
902 |
| CD34 |
CD34 antigen |
|
1q32 |
4502660 |
947 |
| CD44 |
CD44 antigen (homing function and Indian blood group system) |
MIC4, MDU2, MDU3, IN, MC56, Pgp1, MIC4, MDU2, MDU3, CD44R |
11p13 |
M59040 |
960 |
| CDC2 |
cell division cycle 2, G1 to S and G2 to M |
|
10q21.1 |
4502708 |
983 |
| CDC25C |
cell division cycle 25C |
CDC25 |
5q31 |
M34065 |
995 |
| CDC37 |
CDC37 cell division cycle 37 homolog (S. cerevisiae) |
|
19p13.2 |
5901921 |
11140 |
| CDC42 |
cell division cycle 42 (GTP binding protein, 25kDa) |
G25K, CDC42Hs |
1p36.1 |
NM_001791 |
998 |
| CDK2 |
cyclin-dependent kinase 2 |
|
12q13 |
M68520 |
1017 |
| CDK4 |
cyclin-dependent kinase 4 |
PSK-J3 |
12q13 |
U37022 |
1019 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| CDK5 |
cyclin-dependent kinase 5 |
PSSALRE |
7q36 |
4826674 |
1020 |
| CDK6 |
cyclin-dependent kinase 6 |
PLSTIRE |
7q21-q22 |
4502740 |
1021 |
| CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
CDKN1, P21, CIP1, WAF1, SDI1, CAP20 |
6p21.1 |
11386202 |
1026 |
| CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
KIP1, P27KIP1 |
12p13.1-p12 |
S76988 |
1027 |
| CDKN2A |
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
CDKN2, MLM, CDK4I, p16, INK4a, MTS1, CMM2, ARF, p19, p14, INK4 |
9p21 |
U26727 |
1029 |
| CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
P15, MTS2, INK4B |
9p21 |
NM_004936 |
1030 |
| CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
19q13.2 |
14043188 |
1054 |
| CHEK1 |
CHK1 checkpoint homolog (S. pombe) |
CHK1 |
11q24-11q24 |
4502802 |
1111 |
| CHEK1 |
CHK1 checkpoint homolog (S. pombe) |
CHK1 |
11q24-11q24 |
AF016582 |
1111 |
| CHEK2 |
CHK2 checkpoint homolog (S. pombe) |
RAD53, CDS1, CHK2, HuCds1, PP1425, bA444G7 |
22q12.1 |
AF086904 |
11200 |
| CKN1 |
Cockayne syndrome 1 (classical) |
CSA |
5q12.1 |
U28413 |
1161 |
| CLNS1A |
chloride channel, nucleotide-sensitive, 1A |
CLCI, ICln |
11q13.5-q14 |
4502890 |
1207 |
| CLU |
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) |
CLI, APOJ, SGP-2, SP-40, TRPM-2 |
8 |
4502904 |
1191 |
| COX5A |
cytochrome c oxidase subunit Va |
|
15q25 |
BC024240 |
9377 |
| COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
COX6A |
6p21 |
10047079 |
1337 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
16p |
4885148 |
1339 |
| CRABP2 |
cellular retinoic acid binding protein 2 |
CRABP-II |
1q21.3 |
12654550 |
1382 |
| CRIP1 |
cysteine-rich protein 1 (intestinal) |
CRIP |
7q11.23 |
4503046 |
1396 |
| CRIP2 |
cysteine-rich protein 2 |
CRP2, ESP1 |
14q32.3 |
4503048 |
1397 |
| CRKL |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
22q11 |
X59656 |
1399 |
| CSF1 |
colony stimulating factor 1 (macrophage) |
|
1p13-p21 or 5q33 |
BC021117 |
1435 |
| CSNK1E |
casein kinase 1, epsilon |
CSNK1E3, HCKIE |
22q12-q13 |
L37043 |
1454 |
| CSNK1E |
casein kinase 1, epsilon |
HCKIE |
22q12-q13 |
4503092 |
1454 |
| CST6 |
cystatin E/M |
|
11q13 |
U62800 |
1474 |
| CTGF |
connective tissue growth factor |
IGFBP8, CCN2 |
6q23.1 |
4503122 |
1490 |
| CTSB |
cathepsin B |
Cathepsin B |
8p22 |
NM_147783 |
1508 |
| CTSC |
cathepsin C |
PLS, PALS, DPP1 |
11q14.1-q14.3 |
4503140 |
1075 |
| CTSD |
cathepsin D (lysosomal aspartyl protease) |
CPSD |
11p15.5 |
NM_001909 |
1509 |
| CTSE |
cathepsin E |
|
1q31 |
4503144 |
1510 |
| CTSG |
cathepsin G |
CG |
14q11.2 |
4503148 |
1511 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| CTSH |
cathepsin H |
CPSB |
15q24-q25 |
NM_004390 |
1512 |
| CTSL |
cathepsin L |
|
9q21-q22 |
4503154 |
1514 |
| CTSS |
cathepsin S |
|
1q21 |
BC002642 |
1520 |
| CTSZ |
cathepsin Z |
CTSX |
20q13 |
NM_001336 |
1522 |
| CX3CL1 |
chemokine (C-X3-C motif) ligand 1 |
SCYD1, NTN, C3Xkine, ABCD-3, CXC3C, CXC3, fractalkine, neurotactin |
16q13 |
4506856 |
6376 |
| CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
MGSA, GRO1, SCYB1, GROa, MGSA-a, NAP-3 |
4q21 |
4504152 |
2919 |
| CXCL2 |
chemokine (C-X-C motif) ligand 2 |
GRO2, SCYB2, GROb, MIP-2a, MGSA-b, CINC-2a |
4q21 |
M36820 |
2920 |
| CXCL5 |
chemokine (C-X-C motif) ligand 5 |
SCYB5, ENA-78 |
4q13-q21 |
4506848 |
6374 |
| CXCL6 |
chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) |
SCYB6, GCP-2, CKA-3 |
4q21 |
4506850 |
6372 |
| CYCS |
cytochrome c, somatic |
HCS |
7p21.2 |
11128018 |
54205 |
| DAD1 |
defender against cell death 1 |
|
14 |
D15057 |
1603 |
| DNAJC7 |
DnaJ (Hsp40) homolog, subfamily C, member 7 |
TTC2, TPR2 |
17q11.2 |
4507712 |
7266 |
| E2F4 |
E2F transcription factor 4, p107/p130-binding |
|
16q21-q22 |
U15641 |
1874 |
| EDG2 |
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 |
edg-2, rec.1.3, vzg-1, Gpcr26, Mrec1.3 |
9q |
4503456 |
1902 |
| EF1A |
|
|
|
X03558 |
|
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| EGFR |
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) |
ERBB |
7p12 |
U48722 |
1956 |
| EIF1AY |
eukaryotic translation initiation factor 1A, Y-linked |
|
Y |
2580559 |
9086 |
| EIF3S2 |
eukaryotic translation initiation factor 3, subunit 2 beta, 36kDa |
TRIP-1, eIF3-beta, eIF3-p36 |
1p34.1 |
4503512 |
8668 |
| EIF3S3 |
eukaryotic translation initiation factor 3, subunit 3 gamma, 40kDa |
eIF3-gamma, eIF3-p40 |
8q24.11 |
4503514 |
8667 |
| EIF3S6 |
eukaryotic translation initiation factor 3, subunit 6 48kDa |
INT6, eIF3-p46 |
8q22-q23 |
U62962 |
3646 |
| EIF4E |
eukaryotic translation initiation factor 4E |
EIF4EL1, EIF4F |
4q21-q25 |
M15353 |
1977 |
| ELF3 |
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
ESX, EPR-1, ESE-1, ERT |
1q32.2 |
BC003569 |
1999 |
| ELK1 |
ELK1, member of ETS oncogene family |
ELK |
Xp22.1-p11 |
AL009172 |
2002 |
| EMP1 |
epithelial membrane protein 1 |
TMP, CL-20 |
12p12.3 |
Y07909 |
2012 |
| ENO1 |
enolase 1, (alpha) |
ENO1L1, MPB1, PPH, MBP-1, HGNC:7205 |
1p36.2 |
4503570 |
2023 |
| EPS8 |
epidermal growth factor receptor pathway substrate 8 |
|
12q23-q24 |
4758295 |
2059 |
| ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
|
19q13.2-q13.3 |
M13194 |
2067 |
| ESR1 |
estrogen receptor 1 |
ESR, NR3A1, Era |
6q24-q27 |
M12674 |
2099 |
| ETR101 |
immediate early protein |
|
|
XM_051364 |
9592 |
| ETS1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
EWSR2 |
11q23.3 |
X14798 |
2113 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| ETS2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
21q22.3 |
NM_005239 |
2114 |
| F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
1p22-p21 |
J02931 |
2152 |
| FADD |
Fas (TNFRSF6)-associated via death domain |
MORT1 |
11q13.3 |
791037 |
8772 |
| FEN1 |
flap structure-specific endonuclease 1 |
RAD2, FEN-1 |
11q12 |
AC004770 |
2237 |
| FGF13 |
fibroblast growth factor 13 |
FHF2 |
X |
4758365 |
2258 |
| FKBP4 |
FK506 binding protein 4, 59kDa |
FKBP59, FKBP52 |
12p13.33 |
4503728 |
2288 |
| FKBP5 |
FK506 binding protein 5 |
FKBP51, FKBP54, PPIase, P54, Ptg-10 |
6p21.3-21.2 |
4758383 |
2289 |
| FLI1 |
Friend leukemia virus integration 1 |
SIC-1, EWSR2 |
11q24.1-q24.3 |
M98833 |
2313 |
| FN1 |
fibronectin 1 |
|
2q34-q36 |
13543399 |
2335 |
| FOS |
v-fos FBJ murine osteosarcoma viral oncogene homolog |
|
14q24.3 |
V01512 |
2353 |
| FOSL1 |
FOS-like antigen 1 |
fra-1 |
11q13 |
4885242 |
8061 |
| FXYD2 |
FXYD domain containing ion transport regulator 2 |
ATP1G1, HOMG2, HGNC:5052, MGC12372 |
11q23 |
15342033 |
486 |
| FXYD7 |
FXYD domain containing ion transport regulator 7 |
|
19q13.1 |
11612658 |
53822 |
| G1P2 |
interferon, alpha-inducible protein (clone IFI-15K) |
ISG15 |
1 |
4826773 |
9636 |
| GATA3 |
GATA binding protein 3 |
|
10p15 |
BC006793 |
2625 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| GDBR1 |
putative glialblastoma cell differentiation-related |
|
|
7705380 |
10422 |
| GH2 |
growth hormone 2 |
GH-V |
17q22-q24 |
BC020756 |
2689 |
| GJB2 |
gap junction protein, beta 2, 26kDa (connexin 26) |
DFNB1, DFNA3, CX26, NSRD1 |
13q11-q12 |
BC017048 |
2706 |
| GJB2 |
gap junction protein, beta 2, 26kDa (connexin 26) |
DFNB1, DFNA3, CX26, NSRD1 |
13q11-q12 |
6980947 |
2706 |
| GLUL |
glutamate-ammonia ligase (glutamine synthase) |
GLNS |
1q31 |
4504026 |
2752 |
| GNRH1 |
gonadotropin-releasing hormone 1 (leutinizing-releasing hormone) |
GRH, GNRH, LHRH |
8p21-p11.2 |
4504054 |
2796 |
| GPR30 |
G protein-coupled receptor 30 |
CMKRL2, FEG-1, GPCR-Br |
7p22 |
4504090 |
2852 |
| GPR34 |
G protein-coupled receptor 34 |
|
|
4885318 |
2857 |
| GRB2 |
growth factor receptor-bound protein 2 |
|
17q24-q25 |
4504110 |
2885 |
| GRP |
gastrin-releasing peptide |
|
18q21.1-q21.32 |
4504158 |
2922 |
| HCK |
hemopoietic cell kinase |
JTK9 |
20q11-q12 |
M16591 |
3055 |
| HDAC1 |
histone deacetylase 1 |
RPD3L1, HD1, RPD3L1 |
1p34.1 |
D50405 |
3065 |
| HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
HPTA |
7q21.1 |
M73239 |
3082 |
| HMGA1 |
high mobility group AT-hook 1 |
HMGIY |
6p21 |
4504432 |
3159 |
| HOXB7 |
homeo box B7 |
HOX2, HOX2C |
17q21-q22 |
BC015345 |
3217 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
HRAS1 |
11p15.5 |
J0027 |
3265 |
| IBSP |
integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II) |
BSP, SP-II, BSP-II |
4q28-q31 |
J05213 |
3381 |
| ID1 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
|
20q11 |
BC012420 |
3397 |
| ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
2p25 |
D13891 |
3398 |
| IFI27 |
interferon, alpha-inducible protein 27 |
P27 |
14q32 |
5031780 |
3429 |
| IFI35 |
interferon-induced protein 35 |
IFP35 |
17q12-q21 |
12655016 |
3430 |
| IFNA17 |
interferon, alpha 17 |
|
9p22 |
10880984 |
3451 |
| IFNA21 |
interferon, alpha 21 |
|
9p22 |
XM_011766 |
3452 |
| IFNG |
interferon, gamma |
|
12q24.1 |
10835170 |
3458 |
| IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
IFNGT1, AF-1 |
21q22.1 |
5031782 |
3460 |
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
HSIGF1B |
12q22-q23 |
X56774 |
3479 |
| IGF1 |
insulin-like growth factor 1 (somatomedin C) |
HUMIGFIB |
12q22-q23 |
M37484 |
3479 |
| IGFBP1 |
insulin-like growth factor binding protein 1 |
IBP1 |
7p13-p12 |
4504614 |
3484 |
| IGFBP3 |
insulin-like growth factor binding protein 3 |
|
7p13-p12 |
M35878 |
3486 |
| IGFBP4 |
insulin-like growth factor binding protein 4 |
|
17q12-q21.1 |
XM_049937 |
3487 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| IGFBP5 |
insulin-like growth factor binding protein 5 |
|
2q33-q36 |
10834981 |
3488 |
| IGFBP6 |
insulin-like growth factor binding protein 6 |
|
12q13 |
11321592 |
3489 |
| IGFBP7 |
insulin-like growth factor binding protein 7 |
MAC25, IGFBP-7, PSF, FSTL2 |
4q12 |
S75725 |
3490 |
| IGFBP7 |
insulin-like growth factor binding protein 7 |
MAC25, IGFBP-7, PSF, FSTL2 |
4q12 |
L19182 |
3490 |
| IL10 |
interleukin 10 |
CSIF, TGIF, IL10A, IL-10 |
1q31-q32 |
10835140 |
3586 |
| IL11 |
interleukin 11 |
IL-11 |
19q13.3-q13.4 |
10834993 |
3589 |
| IL13 |
interleukin 13 |
P600, IL-13 |
5q31 |
4504644 |
3596 |
| IL1A |
interleukin 1, alpha |
IL1, IL1F1, IL-1A |
2q12-q21 |
13236493 |
3552 |
| IL1B |
interleukin 1, beta |
IL1F2, IL-1B |
2q13-q21 |
10835144 |
3553 |
| IL20 |
interleukin 20 |
ZCYTO10, IL10D, IL-20 |
1q32 |
11036633 |
50604 |
| IL4 |
interleukin 4 |
BSF1, IL-4 |
5q23-q31 |
4504668 |
3565 |
| IL6R |
interleukin 6 receptor |
|
1 |
4504672 |
3570 |
| IL7 |
interleukin 7 |
IL-7 |
8q12-q13 |
4504676 |
3574 |
| IL8 |
interleukin 8 |
SCYB8, LUCT, LECT, MDNCF, TSG-1, CXCL8, IL-8, NAP-1, 3-10C, MONAP, AMCF-I, LYNAP, NAF, b-ENAP, GCP-1, K60 |
4q13-q21 |
10834977 |
3576 |
| IL9 |
interleukin 9 |
IL-9 |
5q31-q35 |
10834979 |
3578 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| INSL5 |
insulin-like 5 |
|
1p31.1-1p22.3 |
5729885 |
10022 |
| INSL6 |
insulin-like 6 |
|
9p24 |
6005789 |
11172 |
| ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
FNRB, MSK12, MDF2, CD29, GPIIA |
10p11.2 |
14495714 |
3688 |
| JUN |
v-jun sarcoma virus 17 oncogene homolog (avian) |
|
1p32-p31 |
J04111 |
3725 |
| JUNB |
jun B proto-oncogene |
|
19p13.2 |
4504808 |
3726 |
| KLK10 |
kallikrein 10 |
PRSSL1, NES1 |
19q13 |
NM_145888 |
5655 |
| KLK3 |
kallikrein 3, (prostate specific antigen) |
APS, PSA |
19q13 |
4502172 |
354 |
| KRT15 |
keratin 15 |
|
17q21-q23 |
4504914 |
3866 |
| KRT19 |
keratin 19 |
|
17q21-q23 |
BC007628 |
3880 |
| KRT8 |
keratin 8 |
CARD2, K8, CK8, CYK8, K2C8, KO |
12q13 |
4504918 |
3856 |
| LCN2 |
lipocalin 2 (oncogene 24p3) |
NGAL |
9q34 |
X99133 |
3934 |
| MAD |
MAX dimerization protein 1 |
MXD1 |
2p13-p12 |
L06895 |
4084 |
| MAFK |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
7p22 |
AF059194 |
7975 |
| MAP2K3 |
mitogen-activated protein kinase kinase 3 |
PRKMK3, MEK3, MKK3 |
17q11.2 |
4506098 |
5606 |
| MAP2K4 |
mitogen-activated protein kinase kinase 4 |
SERK1, MEK4, JNKK1, PRKMK4, MKK4 |
17p11.2 |
4506888 |
6416 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| MAP2K6 |
mitogen-activated protein kinase kinase 6 |
PRKMK6, MEK6, MKK6, SAPKK3 |
|
14589899 |
5608 |
| MAPK10 |
mitogen-activated protein kinase 10 |
PRKM10, JNK3, p493F12, p54bSAPK |
|
4506080 |
5602 |
| MAPK13 |
mitogen-activated protein kinase 13 |
PRKM13, SAPK4, p38delta |
6p21 |
4506084 |
5603 |
| MAPK3 |
mitogen-activated protein kinase 3 |
PRKM3, ERK1, p44mapk, p44erk1 |
16 |
15559270 |
5595 |
| MAPK8 |
mitogen-activated protein kinase 8 |
PRKM8, JNK, JNK1, SAPK1 |
10 |
4506094 |
5599 |
| MAPK9 |
mitogen-activated protein kinase 9 |
PRKM9, JNK2, Jun kinase, p54aSAPK |
5q35 |
NM_139069 |
5601 |
| MAX |
MAX protein |
|
14q23 |
NM_002382 |
4149 |
| MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
GLIF, GIF |
22q11.2 |
NM_002415 |
4282 |
| MMP1 |
matrix metalloproteinase 1 (interstitial collagenase) |
CLG |
11q21-q22 |
BC013875 |
4312 |
| MMP13 |
matrix metalloproteinase 13 (collagenase 3) |
CLG3 |
11q22.3 |
X75308 |
4322 |
| MMP7 |
matrix metalloproteinase 7 (matrilysin, uterine) |
MPSL1, PUMP-1 |
11q21-q22 |
35802 |
4316 |
| MMP7 |
matrix metalloproteinase 7 (matrilysin, uterine) |
MPSL1, PUMP-1 |
11q21-q22 |
13027804 |
4316 |
| MRAS |
muscle RAS oncogene homolog |
M-RAs, R-RAS3, RRAS3 |
3q22.3 |
AF043938 |
22808 |
| MUC1 |
mucin 1, transmembrane |
MUC1/Z, PUM |
1q21-q23 |
U60261 |
4582 |
| MX1 |
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
IFI-78K, MxA |
21q22.3 |
4505290 |
4599 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| MYB |
v-myb myeloblastosis viral oncogene homolog (avian) |
c-myb |
6q22-q23 |
XM_004256 |
4602 |
| MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
c-Myc |
8q24 |
X00364 |
4609 |
| MYCBP |
c-myc binding protein |
AMY-1 |
1p33-p32.2 |
XM_001357 |
26292 |
| NBL1 |
neuroblastoma, suppression of tumorigenicity 1 |
D1S1733E, NB, DAN, NO3 |
1p36.3-p36.2 |
NM_005380 |
4681 |
| NCOA4 |
nuclear receptor coactivator 4 |
ARA70, RFG, ELE1 |
10q11.2 |
X77548 |
8031 |
| NDUFA6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
B14 |
22q13.1 |
4505358 |
4700 |
| NEUROD1 |
neurogenic differentiation 1 |
NEUROD, BETA2, BHF-1, NeuroD |
2q32 |
AB018693 |
4760 |
| NEUROD4 |
neurogenic differentiation 4 |
Atoh3, ATH-3, MATH-3 |
|
10863998 |
58158 |
| NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
NFKB1A, NFKBI, IKBA, MAD-3 |
14q13 |
10092618 |
4792 |
| NR0B2 |
nuclear receptor subfamily 0, group B, member 2 |
SHP |
1p36.1 |
13259502 |
8431 |
| NR1D2 |
nuclear receptor subfamily 1, group D, member 2 |
BD73, RVR, EAR-1r, HZF2, Hs.37288 |
3p24.2 - 24.3 |
2116671 |
9975 |
| NR1H2 |
nuclear receptor subfamily 1, group H, member 2 |
UNR, NER, NER-I, RIP15, UNR, LXR-b |
19q13.3-19q13.3 |
11321629 |
7376 |
| NR1H3 |
nuclear receptor subfamily 1, group H, member 3 |
LXR-a, RLD-1 |
|
5031892 |
10062 |
| NR2E1 |
nuclear receptor subfamily 2, group E, member 1 |
TLX, TLL, XTLL |
6q21 |
4507536 |
7101 |
| NR4A3 |
nuclear receptor subfamily 4, group A, member 3 |
CSMF, CHN, NOR1, MINOR |
9q22 |
S81243 |
8013 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| NUDT1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
MTH1 |
7p22 |
4505274 |
4521 |
| NUDT2 |
nudix (nucleoside diphosphate linked moiety X)-type motif 2 |
APAH1 |
9p13 |
4502124 |
318 |
| NUDT3 |
nudix (nucleoside diphosphate linked moiety X)-type motif 3 |
DIPP |
6p21.2 |
5729803 |
11165 |
| NUDT4 |
nudix (nucleoside diphosphate linked moiety X)-type motif 4 |
DIPP2, HDCMB47P, KIAA0487, DIPP2alpha, DIPP2beta |
12q21 |
10800135 |
11163 |
| NUDT5 |
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
hYSAH1, YSA1H |
10p13-p14 |
AF161464 |
11164 |
| NUDT6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
gfg-1, bFGF, gfg, FGF-2, FGF2AS, FGF-AS |
4q26 |
11095442 |
11162 |
| NUMB |
numb homolog (Drosophila) |
|
14q24.3 |
NM_003744 |
8650 |
| OXCT |
3-oxoacid CoA transferase |
SCOT |
5p13 |
U62961 |
5019 |
| PCNA |
proliferating cell nuclear antigen |
|
20pter-p12 |
4505640 |
5111 |
| PDCD10 |
programmed cell death 10 |
TFAR15 |
|
6005897 |
11235 |
| PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
|
10q24 |
XM_005698 |
27250 |
| PDCD5 |
programmed cell death 5 |
TFAR19 |
19q12-q13.1 |
4759223 |
9141 |
| PDCD6 |
programmed cell death 6 |
ALG-2 |
5p15.2-pter |
7019484 |
10016 |
| PDGFB |
platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) |
SIS |
22q12.3-q13.1 |
M12783 |
5155 |
| PEA15 |
phosphoprotein enriched in astrocytes 15 |
HUMMAT1H, HMAT1, MAT1, PED, PEA-15, MAT1H |
1q21.1 |
BC010469 |
8682 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| PEA15 |
phosphoprotein enriched in astrocytes 15 |
HMAT1, MAT1, PED, PEA-15, MAT1H |
1q21.1 |
4505704 |
8682 |
| PECAM1 |
platelet/endothelial cell adhesion molecule (CD31 antigen) |
|
17q23 |
AF281288 |
5175 |
| PFN1 |
profilin 1 |
|
17p13.3 |
4826897 |
5216 |
| PGLYRP |
peptidoglycan recognition protein |
TNFSF3L, TAG7, PGRP |
19q13.2-q13.3 |
4827035 |
8993 |
| PI3 |
protease inhibitor 3, skin-derived (SKALP) |
ESI, SKALP, ELAFIN, WAP3, WFDC14 |
20q12-20q13 |
4505786 |
5266 |
| PIP |
prolactin-induced protein |
|
7q32-qter |
4505820 |
5304 |
| PLAGL1 |
pleiomorphic adenoma gene-like 1 |
ZAC, LOT1 |
6q24-q25 |
XM_047138 |
5325 |
| PLAUR |
plasminogen activator, urokinase receptor |
URKR, UPAR, CD87 |
19q13 |
X51675 |
5329 |
| PPARG |
peroxisome proliferative activated receptor, gamma |
PPARG1, PPARG2, NR1C3 |
3p25 |
NM_005037 |
5468 |
| PPID |
peptidylprolyl isomerase D (cyclophilin D) |
CYP-40 |
4 |
4826931 |
5481 |
| PRDX2 |
peroxiredoxin 2 |
TDPX1, PRP, NKEFB |
19p13.2 |
L19185 |
7001 |
| PRKCA |
protein kinase C, alpha |
PKCA |
17q22-q24 |
4506066 |
5578 |
| PRKR |
protein kinase, interferon-inducible double stranded RNA dependent |
PKR, EIF2AK1 |
2p22-p21 |
NM_002759 |
5610 |
| PRL |
prolactin |
|
6p22.2-p21.3 |
NM_000948 |
5617 |
| PRLR |
prolactin receptor |
|
5p14-p13 |
M31661 |
5618 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| PROL2 |
|
B4-2 |
|
5802981 |
|
| PRV1 |
polycythemia rubra vera 1 |
|
|
9966888 |
57126 |
| PSIP1 |
PC4 and SFRS1 interacting protein 1 |
p52, LEDGF |
|
11024644 |
|
| PSMD9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
p27 |
12q24.31-q24.32 |
4506234 |
5715 |
| PTEN |
phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
BZS, MHAM, MMAC1, TEP1 |
10q23 |
NM_000314 |
5728 |
| PTGFR |
prostaglandin F receptor (FP) |
FP |
1p31.1 |
4506260 |
5737 |
| PTK9 |
PTK9 protein tyrosine kinase 9 |
A6 |
12q12 |
4506274 |
5756 |
| PTMS |
parathymosin |
|
17q12-q22 |
4506278 |
5763 |
| PTPN1 |
protein tyrosine phosphatase, non-receptor type 1 |
PTP1B |
20q13.1-q13.2 |
M31724 |
5770 |
| RAB26 |
RAB26, member RAS oncogene family |
|
16p13.3 |
7657491 |
25837 |
| RAB31 |
RAB31, member RAS oncogene family |
Rab22B |
18 |
U59877 |
11031 |
| RAB35 |
RAB35, member RAS oncogene family |
H-ray |
12 |
X79781 |
11021 |
| RAB9A |
RAB9A, member RAS oncogene family |
RAB9 |
Xp22.2 |
U44103 |
9367 |
| RAD17 |
RAD17 homolog (S. pombe) |
Rad24, RAD17Sp |
5q13 |
4506382 |
5884 |
| RAD23A |
RAD23 homolog A (S. cerevisiae) |
HHR23A |
19p13.2 |
4826963 |
5886 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| RAD23B |
RAD23 homolog B (S. cerevisiae) |
HHR23B |
9q31.2 |
D21090 |
5887 |
| RAD51 |
RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) |
RAD51A, RECA, RECA, RAD51, HsRad51, RAD51A, HsT16930 |
15q15.1 |
D14134 |
5888 |
| RAD51L1 |
RAD51-like 1 (S. cerevisiae) |
RAD51B, REC2, hREC2, R51H2, RAD51B |
14q23-q24.2 |
U92074 |
5890 |
| RAD52 |
RAD52 homolog (S. cerevisiae) |
|
12p13-p12.2 |
U12134 |
5893 |
| RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
3p25 |
X03484 |
5894 |
| RAP2B |
RAP2B, member of RAS oncogene family |
|
3q25.2 |
BC012362 |
5912 |
| RARB |
retinoic acid receptor, beta |
HAP, NR1B2 |
3p24 |
AF157483 |
5915 |
| RARG |
retinoic acid receptor, gamma |
RARC, NR1B3 |
12q13 |
M38258 |
5916 |
| RFC3 |
replication factor C (activator 1) 3, 38kDa |
|
13q12.3-q13 |
4506488 |
5983 |
| RFC4 |
replication factor C (activator 1) 4, 37kDa |
A1 |
3q27 |
M87339 |
5984 |
| RPL19 |
ribosomal protein L19 |
|
17p12-q11 |
4506608 |
6143 |
| RPL34 |
ribosomal protein L34 |
|
4 or 17 |
BC001773 |
6164 |
| RUVBL1 |
RuvB-like 1 (E. coli) |
TIP49, NMP238 |
3q21 |
4506752 |
8607 |
| S100A11 |
S100 calcium binding protein A11 (calgizzarin) |
S100C |
1q21 |
5032056 |
6282 |
| S100A4 |
S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) |
MTS1, CAPL, P9KA, 18A2, PEL98 |
1q12-q22 |
M80563 |
6275 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| S100A7 |
S100 calcium binding protein A7 (psoriasin 1) |
PSOR1 |
1q21 |
9845518 |
6278 |
| SCGB1A1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
UGB , UGB, CC10 |
11q11-qter |
NM_003357 |
7356 |
| SCGB1A1 |
secretoglobin, family 1A, member 1 (uteroglobin) |
UGB, CC10 |
11q11-qter |
4507808 |
7356 |
| SCGB2A2 |
secretoglobin, family 2A, member 2 |
MGB1, UGB2 |
11q13 |
4505168 |
4250 |
| SERPINB2 |
serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 |
PLANH2, PAI2, HsT1201 |
18q21.3 |
4505594 |
5055 |
| SERPINB5 |
serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5 |
PI5, maspin |
18q21.3 |
BC020713 |
5268 |
| SERPINE1 |
serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
PLANH1, PAI1, PAI |
7q21.3-q22 |
16162125 |
5054 |
| SERPINI2 |
serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 2 |
PI14, PANCPIN, TSA2004, MEPI, pancpin |
3q26 |
10947029 |
5276 |
| SGK |
serum/glucocorticoid regulated kinase |
|
6q23 |
BC001263 |
6446 |
| SHBG |
sex hormone-binding globulin |
|
17pter-p12 |
7382459 |
6462 |
| SIAT7 |
|
STHM |
|
AJ251053 |
|
| SKP2 |
S-phase kinase-associated protein 2 (p45) |
|
5p13 |
5174684 |
6502 |
| SNCG |
synuclein, gamma (breast cancer-specific protein 1) |
BCSG1, SR, persyn |
10q23.2-q23.3 |
BC014098 |
6623 |
| SNCG |
synuclein, gamma (breast cancer-specific protein 1) |
BCSG1, SR, persyn |
10q23.2-q23.3 |
BC014098 |
6623 |
| SOX5 |
SRY (sex determining region Y)-box 5 |
|
12p12.1 |
5902113 |
6660 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
ON, ON |
5q31-q33 |
NM_003118 |
6678 |
| SPOCK |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) |
TIC1 |
5q31 |
X73608 |
6695 |
| SPP1 |
secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) |
BNSP, OPN, BSPI, ETA-1 |
4q11-q21 |
4759165 |
6696 |
| SRA1 |
steroid receptor RNA activator 1 |
SRA, STRAA1 |
5 |
9930609 |
10011 |
| SST |
somatostatin |
|
3q28 |
4507242 |
6750 |
| STK17B |
serine/threonine kinase 17b (apoptosis-inducing) |
DRAK2 |
|
4758193 |
9262 |
| SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
STP, STP1, P-PST |
16p12.1 |
NM_003166 |
6817 |
| SULT2A1 |
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA) -preferring, member 1 |
STD, DHEA-ST |
19q13.3 |
4507306 |
6822 |
| TACSTD1 |
tumor-associated calcium signal transducer 1 |
M4S1, MIC18, Ly74, M4S1, TROP1, GA733-2, EGP, KSA, HGNC:7081 |
2p21 |
M93036 |
4072 |
| TACSTD2 |
tumor-associated calcium signal transducer 2 |
M1S1, TROP2, GA733-1, EGP-1 |
1p32 |
X77753 |
4070 |
| TAF10 |
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
TAF2H, TAF2A, TAFII30 |
11p15.5-p15.2 |
U13991 |
6881 |
| TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
|
20q13.2 |
4507444 |
7022 |
| TFF1 |
trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in) |
BCEI, D21S21, HPS2 |
21q22.3 |
NM_003225 |
7031 |
| TGFB1 |
transforming growth factor, beta 1 (Camurati-Engelmann disease) |
TGFb1, TGFB, DPD1, CED, HGNC:2997 |
19q13.1 |
BC000125 |
7040 |
| TGFB3 |
transforming growth factor, beta 3 |
|
14q24 |
5032176 |
7043 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| TGFB3 |
transforming growth factor, beta 3 |
|
14q24 |
4507464 |
7043 |
| TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
|
3p22 |
4507468 |
7048 |
| THRA |
thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) |
THRA1, THRA2, ERBA1, EAR-7.1/EAR-7.2, THRA3, AR7, ERBA, NR1A1 |
17q11.2-17q12 |
M24898 |
7067 |
| TNF |
tumor necrosis factor (TNF superfamily, member 2) |
TNFA, TNFSF2, DIF |
6p21.3 |
10835154 |
7124 |
| TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
DR5, KILLER, TRICK2A, TRAIL-R2, TRICKB |
8p22-p21 |
4507560 |
8795 |
| TNFRSF17 |
tumor necrosis factor receptor superfamily, member 17 |
BCMA, BCM |
16p13.1 |
4507572 |
608 |
| TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
TNFR1, TNF-R, TNFAR, TNFR60, TNF-R-I, CD120a, TNF-R55 |
12p13.2 |
4507574 |
7132 |
| TNFRSF9 |
tumor necrosis factor receptor superfamily, member 9 |
ILA, CD137, 4-1BB |
1p36 |
NM_001561 |
3604 |
| TNFSF6 |
tumor necrosis factor (ligand) superfamily, member 6 |
APT1LG1, FasL, CD178 |
1q23 |
D38122 |
356 |
| TP53 |
tumor protein p53 (Li-Fraumeni syndrome) |
P53 |
17p13.1 |
U94788 |
7157 |
| TRIM26 |
tripartite motif-containing 26 |
ZNF173, RNF95 |
6p21.3 |
U09825 |
7726 |
| TSG101 |
tumor susceptibility gene 101 |
TSG10, HGNC:12368 |
11p15 |
BC002487 |
7251 |
| TTC4 |
tetratricopeptide repeat domain 4 |
|
1p31 |
4759271 |
7268 |
| TYMS |
thymidylate synthetase |
TS, Tsase, TMS, HsT422 |
18p11.31-p11.21 |
4507750 |
7298 |
| UBE2B |
ubiquitin-conjugating enzyme E2B (RAD6 homolog) |
UBC2, HHR6B |
5q23-q31 |
4507770 |
7320 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| UBE2B |
ubiquitin-conjugating enzyme E2B (RAD6 homolog) |
UBC2, HHR6B |
5q23-q31 |
M74525 |
7320 |
| UNRIP |
unr-interacting protein |
|
|
6005931 |
11171 |
| VEGF |
vascular endothelial growth factor |
VEGFA |
6p21-p12 |
AF022375 |
7422 |
| VEGFB |
vascular endothelial growth factor B |
VRF, VEGFL |
11q13 |
4507886 |
7423 |
| VEGFC |
vascular endothelial growth factor C |
VRP |
4q33-4q34 |
4885652 |
7424 |
| WNT10B |
wingless-type MMTV integration site family, member 10B |
|
12q13 |
NM_003394 |
7480 |
| WNT11 |
wingless-type MMTV integration site family, member 11 |
|
11q13.5 |
NM_004626 |
7481 |
| WNT14 |
|
|
|
15082260 |
|
| WNT2 |
wingless-type MMTV integration site family member 2 |
INT1L1, IRP |
7q31 |
4507926 |
7472 |
| WNT2 |
wingless-type MMTV integration site family member 2 |
INT1L1, IRP |
7q31 |
X07876 |
7472 |
| WNT5A |
wingless-type MMTV integration site family, member 5A |
|
3p21-p14 |
L20861 |
7474 |
| WNT7A |
wingless-type MMTV integration site family, member 7A |
|
3p25 |
NM_004625 |
7476 |
| WWOX |
WW domain containing oxidoreductase |
FOR |
16q23.3-q24.1 |
7706522 |
51741 |
| XPA |
xeroderma pigmentosum, complementation group A |
XPAC |
9 |
D14533 |
7507 |
| YWHAE |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
14-3-3 epsilon |
17p13 |
U54778 |
7531 |
| gene symbol |
gene name |
aliases |
chromosome |
GenBank |
LocusLink |
| |
Similar to RIKEN cDNA 5830446M03 gene |
|
|
13325245 |
|
| |
transmembrane4 superfamily member 1 |
|
|
14250074 |
|
| |
similar to thyroid hormone receptor |
|
|
BC035137 |
|
| |
Similar to transforming growth factor, alpha, clone |
|
|
13529046 |
|